Patient preferences in prostate cancer: a clinician's guide to understanding health utilities
- PMID: 15992457
- DOI: 10.3816/cgc.2005.n.007
Patient preferences in prostate cancer: a clinician's guide to understanding health utilities
Abstract
Prostate cancer treatments have positive and negative outcomes that must be taken into account when deciding how to proceed with a patient's care. One way to quickly determine a patient's preferences in this situation is to ascertain their health utilities for various health states. Health utilities are underutilized but powerful tools in aiding shared decision making between patients and physicians. This review is intended to inform physicians about the different techniques available, help the physician choose among them, and aid initial development of utilities for use in the clinic by way of the tables' references. A brief history, summary of applications and current directions of health utilities, and collection of references are provided to increase the reader's overall knowledge of health utilities and encourage their use in the clinic. Ultimately, the use and choice of one of these direct preference-based measures depends on the needs of the physician.
Similar articles
-
Health literacy and shared decision making for prostate cancer patients with low socioeconomic status.Cancer Invest. 2001;19(7):684-91. doi: 10.1081/cnv-100106143. Cancer Invest. 2001. PMID: 11577809
-
Pilot study of a utilities-based treatment decision intervention for prostate cancer patients.Clin Prostate Cancer. 2002 Sep;1(2):105-14. doi: 10.3816/cgc.2002.n.012. Clin Prostate Cancer. 2002. PMID: 15046701
-
Doctors' and patients' preferences for participation and treatment in curative prostate cancer radiotherapy.J Clin Oncol. 2007 Jul 20;25(21):3096-100. doi: 10.1200/JCO.2006.07.4955. J Clin Oncol. 2007. PMID: 17634489
-
Shared decision-making in the care of a patient with food allergy.Ann Allergy Asthma Immunol. 2020 Sep;125(3):262-267. doi: 10.1016/j.anai.2020.05.031. Epub 2020 Jun 3. Ann Allergy Asthma Immunol. 2020. PMID: 32504666 Review.
-
Active surveillance for prostate cancer with selective delayed definitive therapy.Clin Prostate Cancer. 2005 Jun;4(1):45-9. doi: 10.3816/cgc.2005.n.011. Clin Prostate Cancer. 2005. PMID: 15992461 Review.
Cited by
-
Incidence of genitourinary complications following radiation therapy for localised prostate cancer.World J Urol. 2022 Oct;40(10):2411-2422. doi: 10.1007/s00345-022-04124-x. Epub 2022 Aug 11. World J Urol. 2022. PMID: 35951087 Free PMC article.
-
Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities.BMC Med Inform Decis Mak. 2009 Nov 27;9:47. doi: 10.1186/1472-6947-9-47. BMC Med Inform Decis Mak. 2009. PMID: 19941668 Free PMC article. Clinical Trial.
-
Factors that influence patient preferences for prostate cancer management options: A systematic review.Patient Prefer Adherence. 2015 Jul 2;9:899-911. doi: 10.2147/PPA.S83333. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26170640 Free PMC article. Review.
-
Changes in health state utilities with changes in body mass in the Diabetes Prevention Program.Obesity (Silver Spring). 2009 Dec;17(12):2176-81. doi: 10.1038/oby.2009.114. Epub 2009 Apr 23. Obesity (Silver Spring). 2009. PMID: 19390518 Free PMC article. Clinical Trial.
-
High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy?Ann Oncol. 2015 Jul;26(7):1390-5. doi: 10.1093/annonc/mdv185. Epub 2015 Apr 28. Ann Oncol. 2015. PMID: 25926039 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical